홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

포시노프라트

Fosinoprilat

HCID 62956
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
95399-71-6
표준 SMILES
O=C(O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCc1ccccc1
InChIKey
WOIWWYDXDVSWAZ-RTWAWAEBSA-N
분자식
C23H34NO5P
평균 분자량
435.5 g/mol
단동위원소 질량
435.21746018

개요

Fosinoprilat is a phosphinic acid-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. An inhibitor of angiotensin converting enzyme (ACE), it is used as the phosphinate ester pro-drug fosinopril for treatment of hypertension and chronic heart failure. It has a role as an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor and an antihypertensive agent. It is a member of phosphinic acids and a L-proline derivative.

이름 및 식별자

우선 이름
Fosinoprilat
IUPAC
(2S,4S)-4-cyclohexyl-1-[2-[hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
현지명
포시노프라트
영어명
FOSINOPRILAT
분자식
C23H34NO5P
분자량
435.49

이름 및 동의어

Fosinoprilat95399-71-6fosfenoprilFosinopril diacidFosinoprilic acidFosinoprilatumSQ-27519SQ 27,519PU6BA2D2MD(4S)-4-Cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphinyl)acetyl)-L-prolineS312EY6ZT8SO-27519
이름 더 보기
포시노프라트FospenoprilForsinoprilatFosinoprilat-D5fosinoprilicacidFosinopril ImpuritySQ 27519 Disodium Salt
CHEBI:116962DTXSID80869253L-Proline, 4-cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphinyl)acetyl)-, trans-(4S)-4-cyclohexyl-1-{[hydroxy(4-phenylbutyl)phosphoryl]acetyl}-L-proline(4S)-4-cyclohexyl-1-((hydroxy(4-phenylbutyl)phosphoryl)acetyl)-L-proline(2S,4S)-4-cyclohexyl-1-(2-(hydroxy-(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylic acid(2S,4S)-4-cyclohexyl-1-[2-(hydroxy-(4-phenylbutyl)phosphoryl)acetyl]pyrrolidine-2-carboxylic acidRefChem:57081

데이터베이스 식별자

CAS
95399-71-6
PubChem CID
62956
DTXSID
DTXSID80869253

물성

구조 계산 물성

XLogP
3.8
극성 표면적
94.9 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
5
회전 가능 결합 수
9
무거운 원자 수
30
형식 전하
0
복잡도
627

실험 및 물리화학적 성질

LogP4.08

물리화학적 성질

녹는점
3000 C · >3000C
끓는 점
728.9 · 728.9±60.0 °C(Predicted)
밀도
1.238 · 1.238±0.06 g/cm3(Predicted)
저장 조건
-20 °C · -20°C Freezer
용해도
메탄올(약간 용해됨), 물(약간 용해됨)
산도 계수 (pKa)
2.75 · 2.75±0.50(Predicted)
물리적 상태
고체
색상
흰색에서 황백색까지
안정성
흡습성
주요 응용
의약품(소분자)
InChIKey
WOIWWYDXDVSWAZ-RTWAWAEBSA-N
SMILES
[P](=O)(O)(CCCCc3ccccc3)CC(=O)N1[C@@H](C[C@H](C1)C2CCCCC2)C(=O)O

화학적 성질

White Crystalline Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

유해성 정보

Regulatory InformationL-Proline, 4-cyclohexyl-1-hydroxy(4-phenylbutyl)phosphinylacetyl-, (4S)-: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesRepr. 1A (100%)

안전 데이터

wgk
3
HS 번호
2933995300
Hazard Classifications
Repr. 1A
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

FDA Pharmacological Classification · 5건

S312EY6ZT8

FOSINOPRILAT

Established Pharmacologic Class [EPC] - Angiotensin Converting Enzyme Inhibitor

Mechanisms of Action [MoA] - Angiotensin-converting Enzyme Inhibitors

Fosinoprilat is an Angiotensin Converting Enzyme Inhibitor. The mechanism of action of fosinoprilat is as an Angiotensin-converting Enzyme Inhibitor.

MeSH Pharmacological Classification · 3건

A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

응용 분야

용도Fosinoprilat (Fosinopril EP Impurity A) is a metabolite of Fosinopril (F727800), a phosphinic acid containing angiotensin converting enzyme (ACE) inhibitor.

공급사37 곳

国药集团化学试剂有限公司86-21-63210123 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
ChEMBL
CHEMBL581
ChEBI
CHEBI:116962
UNII
S312EY6ZT8
EC Number
110-994-9
Nikkaji
J261.896F
艾吉析科技(上海)有限公司
17717235263 · [email protected]
成都彼样生物科技有限公司18108052721 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
江苏艾康生物医药研发有限公司025-66061636 19370895928 · [email protected]
孟成科技(上海)有限公司400-820-6829 · [email protected]
希瓦生物科技(广州)有限公司13268215580 · [email protected]
上海稳同科技有限公司02151600108 13062666369 · [email protected]
Moxin Chemicals+86-17320513646 +86-17320513646 · [email protected]
TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
Cato Research Chemicals Inc.020-81960175 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
常州翔龙医药科技有限公司18915873328 18915873328 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
河南誉康卓宁进出口有限公司13393721940 · [email protected]
艾吉析科技(上海)有限公司17717235263 17717235263 · [email protected]
sgtlifesciences pvt ltd+91-8790379245 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
合肥瑞科昇生物科技有限公司0551-66336380 18956014586 · [email protected]
广州市桐晖药业有限公司020-66392521-118 18922260391 · [email protected]
湖北摩科化学有限公司18627753421; 18627756402 · [email protected]
Aladdin Scientific[email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 18012923235 · [email protected]
Nextpeptide Inc+86-0571-81612335 +8613336028439 · [email protected]
上海相辉医药科技有限公司13611835272 13611835272 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]
上海择睿生物科技有限公司021-54580889 18321124657 · [email protected]
南京世洲生物科技有限公司17301488900 · [email protected]
湖北清北云研医药科技有限责任公司18162595016; 18162595016 · [email protected]
추가 설명 · 1건

정의ChEBI: A phosphinic acid-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. An inhibitor of angiotensin converting enzyme (ACE), it is used as the phosphinate ester pro-drug fosinopril for treatment of ypertension and chronic heart failure.